课题基金 / 基金详情

项目摘要

项目成果

CARL S. THUMMEL的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):动物生活在以热休克、氧化应激、缺氧、感染和来自环境的毒性挑战等形式对其生存的持续威胁中。为了对抗这些威胁并维持动态平衡,动物进化出了复杂而特定的调控反应,其中包括对关键防御基因的协调转录控制。这些调控网络中的许多已经在果蝇黑腹果蝇中被识别和表征,并被证明是通过进化而保守的,为了解它们在人类中的控制提供了基础。这些反应也为高等生物体中协调转录控制的分子机制提供了关键的见解。值得注意的是,动物最关键的防御反应之一--解毒有害化学物质的能力--还没有用简单的遗传模型系统来表征。这些化合物包括药物、杀虫剂、植物毒素和污染物,统称为异生物质,是癌症和呼吸道疾病的关键风险因素。异种生物反应也仍然是制药业开发新药的主要障碍。我们已经证明,用一种广泛使用的异物,镇静剂苯巴比妥治疗果蝇,会导致基因表达的快速、广泛和协调变化。许多受苯巴比妥调控的基因编码酶,并提出了与解毒、保护、药物运输或排泄一致的功能。DHR96-脊椎动物异生受体PXR和CAR的单一祖先苍蝇同源基因-的零突变影响了其中一些基因的苯巴比妥调节,表明DHR96可以通过促进昆虫的异生反应而发挥与脊椎动物同行相同的功能。然而,在缺乏DHR96的情况下,大多数基因都能受到药物的适当调控,这一效应也出现在小鼠的PXR和CAR突变体中,这引发了如何控制这种协调转录电路的问题。这项提议的目的是用果蝇来确定异种转录反应的分子机制。我们将确定苯巴比妥调节所需的关键启动子序列 转录,并确定赋予这种控制的反式作用因子的特征。我们还将确定DHR96参与异种转录反应的分子机制。 这项研究将为包括人类在内的高等生物如何应对有毒物质提供新的见解。 环境中的化合物,并建立果蝇作为一种新的模式系统 异种生物反应调控。
英文摘要
DESCRIPTION (provided by applicant): Animals live with constant threats to their survival in the form of heat shock, oxidative stress, hypoxia, infection, and toxic challenges from the environment. To combat these threats and maintain homeostasis, animals have evolved complex and specific regulatory responses that include the coordinated transcriptional control of key defensive genes. Many of these regulatory networks have been identified and characterized in the fruit fly Drosophila melanogaster, and shown to be conserved through evolution, providing a foundation for understanding their control in humans. These responses have also provided key insights into the molecular mechanisms of coordinate transcriptional control in higher organisms. Remarkably, one of the most critical defense responses in animals - the ability to detoxify harmful chemicals - has not yet been characterized using a simple genetic model system. These compounds, which include pharmaceuticals, pesticides, plant toxins, and pollutants, referred to collectively as xenobiotics, comprise a critical risk factor for cancer and respiratory diseases. Xenobiotic responses also remain a major impediment to the development of new drugs by the pharmaceutical industry. We have shown that treatment of Drosophila with a widely used xenobiotic, the sedative phenobarbital, results in a rapid, widespread, and coordinate change in gene expression. Many phenobarbital-regulated genes encode enzymes and have proposed functions consistent with detoxification, protection, drug transport, or excretion. A null mutation in DHR96 - the single ancestral fly ortholog of the vertebrate xenobiotic receptors PXR and CAR - affects the phenobarbital regulation of some of these genes, demonstrating that DHR96 can function like its vertebrate counterparts by contributing to xenobiotic responses in insects. Most genes, however, are properly regulated by drug in the absence of DHR96, an effect also seen in mouse PXR and CAR mutants, raising the question of how this coordinate transcriptional circuit is controlled. The goal of this proposal is to use Drosophila to define the molecular mechanisms of xenobiotic transcriptional responses. We will identify critical promoter sequences that are required for phenobarbitalregulated transcription and characterize the trans-acting factors that confer this control. We will also determine the molecular mechanisms by which DHR96 contributes to xenobiotic transcriptional responses. This research will provide new insights into how higher organisms, including humans, cope with toxic compounds in their environment and establish Drosophila as a new model system for characterizing xenobiotic response regulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Studies of Diabetes
  • 批准号:
    9233719
  • 项目类别:
  • 资助金额:
    $37.76万
  • 财政年份:
    2016
  • 负责人:
    CARL S. THUMMEL
  • 依托单位:
Genetic Studies of Diabetes
  • 批准号:
    9358416
  • 项目类别:
  • 资助金额:
    $37.9万
  • 财政年份:
    2016
  • 负责人:
    CARL S. THUMMEL
  • 依托单位:
Genetic Studies of Diabetes
  • 批准号:
    9770835
  • 项目类别:
  • 资助金额:
    $38.13万
  • 财政年份:
    2016
  • 负责人:
    CARL S. THUMMEL
  • 依托单位:
Epigenetic regulation of metabolism in Drosophila
  • 批准号:
    8435971
  • 项目类别:
  • 资助金额:
    $28.5万
  • 财政年份:
    2013
  • 负责人:
    CARL S. THUMMEL
  • 依托单位:
海外基金